Phase 1 success for 'Treg immunotherapy' of type 1 diabetes

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:3 / 3
页数:1
相关论文
共 50 条
  • [41] Treg Immunotherapy Requirements in Autoimmune Diabetes
    Cabello, Cecilia
    Pugliese, Alberto
    Pileggi, Antonello
    Bayer, Allison L.
    DIABETES, 2013, 62 : A445 - A446
  • [42] Detection Th1/Treg cells and serum cytokines in fulminant type 1 diabetes
    She, Yuqing
    Gong, Weijuan
    Liu, Zelong
    Hu, Chunxia
    Han, Sen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (10): : 10824 - 10832
  • [43] Risk variants disrupting enhancers of TH1 and TREG cells in type 1 diabetes
    Gao, Peng
    Uzun, Yasin
    He, Bing
    Salamati, Sarah E.
    Coffey, Julie K. M.
    Tsalikian, Eva
    Tan, Kai
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (15) : 7581 - 7590
  • [44] Implementing an Early Type 1 Diabetes Clinic and Immunotherapy Treatment Program for Patients with Stage 1 and Stage 2 Type 1 Diabetes
    Simmons, Kimber M.
    Chesshir, Lexie
    O'Donnell, Holly K.
    Walker, Sonya C.
    Martinez, Andres D.
    Alonso, Guy T.
    Triolo, Taylor M.
    Gottlieb, Peter
    Frohnert, Brigitte I.
    Steck, Andrea
    DIABETES, 2024, 73
  • [45] Effect of Type 1 Diabetes Risk Loci on Duration of Honeymoon Phase in Type 1 Diabetes
    Moosavi, Mandana
    Polychronakos, Constantin
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [46] Epitope-based precision immunotherapy of Type 1 diabetes
    Fite, Rebuma Firdessa
    Genzano, Camillo Bechi
    Mallone, Roberto
    Creusot, Remi J. J.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [47] Peptide Immunotherapy for Type 1 Diabetes-Clinical Advances
    Smith, Emma L.
    Peakman, Mark
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [48] Immunotherapy in type 1 diabetes: Novel pathway to the future ahead
    Ray, Sayantan
    Palui, Rajan
    WORLD JOURNAL OF DIABETES, 2024, 15 (10)
  • [49] Immunotherapy of type 1 diabetes: update on recent clinical trials
    Laporte-Daube, Caroline
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2013, 17 (03): : 55 - 59
  • [50] Immunotherapy in type 1 diabetes mellitus. Quo vadis?
    Fernandez-Balsells, Merce
    Sojo-Vega, Lidia
    Ricart-Engel, Wifredo
    AVANCES EN DIABETOLOGIA, 2013, 29 (06): : 161 - 168